Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
0(0%)
Results Posted
73%(11 trials)

Phase Distribution

Ph phase_3
4
24%
Ph phase_4
4
24%
Ph phase_2
9
53%

Phase Distribution

0

Early Stage

9

Mid Stage

8

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
9(52.9%)
Phase 3Large-scale testing
4(23.5%)
Phase 4Post-market surveillance
4(23.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Completed(15)
Terminated(1)
Other(1)

Detailed Status

Completed15
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 29 (52.9%)
Phase 34 (23.5%)
Phase 44 (23.5%)

Trials by Status

withdrawn16%
unknown16%
completed1588%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17